Vivo Ventures VII Affiliates Fund, L.P., 10% Owner at Aclaris Therapeutics, Inc. (ACRS), sold 650,000 shares at $30.98 ($20.1M) on 2017-03-01, disclosed to the SEC on 2017-03-02.
Open-market sale of $20.1M ACRS by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $30.50 | 4,266 | $130K | 0.6% |
| 2 | $30.50 | 195,734 | $6.0M | 29.7% |
| 3 | $30.98 | 2,133 | $66K | 0.3% |
| 4 | $30.98 | 2,133 | $66K | 0.3% |
| 5 | $30.98 | 97,867 | $3.0M | 15.1% |
| 6 | $30.98 | 97,867 |
| $3.0M |
| 15.1% |
| 7 | $31.20 | 2,666 | $83K | 0.4% |
| 8 | $31.20 | 2,666 | $83K | 0.4% |
| 9 | $31.20 | 122,334 | $3.8M | 19.0% |
| 10 | $31.20 | 122,334 | $3.8M | 19.0% |
| Total | $30.92 avg | 650,000 | $20.1M | 100% |
| Filing → |
| MEIP | SELL | 2013-10-29 | $2.5M | — | Filing → |
| MEIP | SELL | 2013-06-13 | $1.8M | — | Filing → |